Abstract
Metastasis is a complex process whereby tumour cells from a primary neoplastic growth disseminate throughout the body and establish secondary tumour foci in distant organs. Biochemical traits associated with, or essential for, the expression of the metastatic phenotype have not yet been identified1,2. In the course of examining stimulation of the B16 murine melanoma adenylate cyclase by melanocyte-stimulating hormone (MSH) and by the diterpene forskolin, we noted that tumour cell clones3–5 isolated from common parent cell populations differed widely in their responses to these agonists. We report here that the accumulation of cyclic AMP induced by MSH or forskolin shows a strong positive correlation with the ability of B16 melanoma clones to form pulmonary tumour colonies when injected intravenously (i.v.) into syngeneic mice (‘experimental metastasis’). In parallel in vitro analyses of cyclic AMP metabolism and in vivo assays of experimental metastasis using replicate cell preparations, highly metastatic tumour cell clones consistently show greater than a 30-fold increase in cellular cyclic AMP when exposed to MSH or forskolin. By contrast, clones with limited metastatic abilities respond to the same agonists with only a two- to threefold increase in cellular cyclic AMP. These data suggest that cyclic AMP metabolism is linked with biochemical pathways that are responsible for the formation of experimental metastasis by the B16 melanoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fidler, I. J. & Kripke, M. L. Science 197, 893–895 (1977).
Nowell, P. C. Science 194, 23–28 (1976).
Fidler, I. J. & Poste, G. in Tumor Cell Heterogeneity (eds Owens, A. P., Coffey, D. S. & Baylin, S. B.) 127–145 (Academic, New York, 1982).
Poste, G., Doll, J. & Fidler, I. J. Proc. natn. Acad. Sci. U.S.A. 78, 6226–6230 (1981).
Harris, J. F., Chambers, A. F., Hill, R. P. & Ling, V. Proc. natn. Acad. Sci. U.S.A. 79, 5547–5551 (1982).
Poste, G. & Fidler, I. J. Nature 283, 139–146 (1980).
Poste, G. et al. Cancer Res. 42, 4086–4089 (1982).
Greig, R. G. et al. Cancer Res. 43, 6057–6065 (1983).
Pawelek, J. et al. Proc. natn. Acad. Sci. U.S.A. 72, 951–955 (1975).
Seaman, K. B., Padgett, W. & Daly, J. W. Proc. natn. Acad. Sci. U.S.A. 78, 3363–3367 (1981).
Insel, P. A., Stengel, D., Ferry, N. & Hanoune, J. J. biol. Chem. 257, 7485–7490 (1982).
Jakobs, K. H., Aktories, K. & Schultz, G. Nature 303, 177–178 (1983).
Nicolson, G. L. & Poste, G. Curr. Problems Cancer 8, 4–42 (1983).
Kebabian, J. & Nathanson, J. H. Cyclic Nucleotides: Physiology and Pharmacology (Springer, Berlin, 1982).
Howard, R. F., Glossmann, H., Friis, R. R. & Sheppard, J. R. Expl Cell Res. 139, 436–439 (1982).
Howard, R. F., Friis, R., Sheppard, J. R. & Glossmann, H. J. cell. Physiol. 111, 295–302 (1982).
Niles, R. M. & Makarski, J. S. J. cell. Physiol. 96, 355–360 (1978).
Niles, R. M. & Logue, M. P. J. supramolec. Struc. 11, 251–258 (1979).
Fidler, I. J. & Hart, I. R. Science 217, 998–1003 (1982).
Levinson, W., Opperman, H. & Jackson, J. Biochim. biophys. Acta 606, 170–180 (1980).
Sheppard, J. R. et al. in The Red Cell (ed. Brewer, G.) 491–502 (Liss, New York, 1981).
Lowrie, D. B., Jackett, B. S. & Ratcliffe, N. A. Nature 254, 600–602 (1975).
Confer, D. L. & Eaton, J. W. Science 217, 948–950 (1982).
Busby, S. J. W., Aiba, H. & deCrombruggle, B. J. molec. Biol. 154, 211–227 (1982).
Devreotes, P. N. in Development of Dictyostelium Discoideum (ed. Loomis, W. F.) 117–168 (Academic, New York, 1982).
Mangiarotti, G., Ceccarelli, A. & Lodish, H. F. Nature 301, 616–618 (1983).
Lowry, O. H. et al. J. biol. Chem. 193, 265–275 (1951).
Hart, I. R. Am. J. Path. 97, 587–600 (1979).
Fidler, I. J. et al. J. natn. Cancer Inst. 67, 947–959 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheppard, J., Koestler, T., Corwin, S. et al. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Nature 308, 544–547 (1984). https://doi.org/10.1038/308544a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/308544a0
This article is cited by
-
Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells
British Journal of Cancer (2003)
-
Modulation of tumor cell gene expression and phenotype by the organspecific metastatic environment
Cancer and Metastasis Reviews (1995)
-
Enhancement of pulmonary metastasis formation and ?-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro
Clinical & Experimental Metastasis (1993)
-
Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis
Cancer and Metastasis Review (1992)
-
A positive association between agonist-induced cyclic AMP production in vitro and metastatic potential in murine B16 melanoma and hamster fibrosarcoma
Clinical & Experimental Metastasis (1990)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.